
TSE:MFC
This summary was created by AI, based on 27 opinions in the last 12 months.
Manulife Financial (MFC) is viewed positively by many experts, who highlight its strong performance in Asia and robust wealth management services. The company is seen as a good long-term investment, particularly due to its attractive dividend yield and relatively low price-to-earnings ratio compared to banks. However, there are concerns regarding short-term earnings fluctuations, particularly in alternative portfolio results and U.S. operations. Market analysts suggest that while the stock has had a good run, cautious investors should watch for strategic entry points, as some believe it may be susceptible to macroeconomic challenges. Overall, the sentiment is that MFC is a solid income stock with potential for growth as it continues to navigate its complex business landscape.
Has started to not do so well over the last little bit. Probably because of the great rotation of money coming out of bonds and going into stocks. However, sales growth has been very strong across all regions. Core earnings have been very good. Last quarter was not messy at all. However, they are having higher costs from new business strain. Probably a good buy at these levels.
Several issues with lifecos. With low interest rates, can they live up to their actuarial assumption? Also, exposure to the Europe bond market. Those things are probably behind them now so the question is, are they just good old solid financials now. In his mind, none of them stack up to being as good as the strongest bank.
Has done well over the last 3-4 months as they’ve hedged more and more of their exposure to both equity markets and interest-rates. Unhedged portion is certainly benefiting from the increase in markets globally. Still a reasonable multiple. Feels it is the best run Canadian insurance company. The particular attraction here is their growth in Asia. Dividend yield is modest but relatively secure at these levels.
In the early stages of a recovery. Stock has performed reasonably well in the last little while. From an earnings standpoint, have really re-engineered its business and gotten out of some of the riskier areas and focused again on growing in Asia and the US. Will return to some normal level of profitability this year, which more than covers the dividend and leaves room for growth. If interest rates start to rise, as he expects it will in 2014, all the lifecos will be huge beneficiaries.
Broader issues that are driving insurance companies are effectively interest rates. Until we see a rise in interest rates, they will constantly be under pressure and it will be hard for them to grow. Longer-term, in an environment where the US improves, more employment is secure, Canada stabilizes and there is growth in Asia, you will see higher earnings and this is a company to buy and hold. There are other alternatives.
Core earnings have been great for a very long time, held hostage by lower interest rates and choppy equity markets. If equity markets improve, that’s going to really help them with their legacy and if interest rates gently push their way up, it is going to make it much harder to roll into the bond market. 3.64% yield.
If you own, you have done very well. However, recently, it broke a support level, established a downward trend and is now underperforming the market. Below its 20 day moving average. Now is the time to take some profits.